Publication: Cytotoxicity against cholangiocarcinoma and HepG2 cell lines of lignan derivatives from Hernandia nymphaeifolia
Issued Date
2018-08-01
Resource Type
ISSN
15548120
10542523
10542523
Other identifier(s)
2-s2.0-85049671953
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Medicinal Chemistry Research. Vol.27, No.8 (2018), 2042-2049
Suggested Citation
Jittra Suthiwong, Jaroon Wandee, Siripit Pitchuanchom, Punchapat Sojikul, Veerapol Kukongviriyapan, Chavi Yenjai Cytotoxicity against cholangiocarcinoma and HepG2 cell lines of lignan derivatives from Hernandia nymphaeifolia. Medicinal Chemistry Research. Vol.27, No.8 (2018), 2042-2049. doi:10.1007/s00044-018-2214-9 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/45486
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cytotoxicity against cholangiocarcinoma and HepG2 cell lines of lignan derivatives from Hernandia nymphaeifolia
Abstract
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. Twelve lignan derivatives were synthesized from deoxypodophyllotoxin isolated from Hernandia nymphaeifolia. Cytotoxicity evaluation against cholangiocarcinoma, KKU-100, and HepG2 cell lines showed that compounds 3, 9, 10, and 13 exhibited stronger cytotoxicity than the starting material, 1, with IC 50 ranging from 0.42 to 2.01 μM. Compound 10 displayed interesting activity by showing IC 50 values of 0.75 and 0.46 μM against KKU-100 and HepG2 cell lines, respectively. From these observation, 10 seems to be useful as a lead compound for the development of anticancer agents.